Recce Pharmaceuticals Ltd. announced the appointment of Alistair McKeough to its Board of Directors. Additionally, Maggie Niewidok has joined as Company Secretary. Both appointments are effective as of September 1, 2022. Mr. McKeough is a successful lawyer and operating executive with significant experience as a Board Director across various sectors from biotech and finance to charities. He has extensive leadership experience driving the growth of
high-performing companies, having been responsible for a range of organizational performance outcomes, including safety and risk management, corporate governance, legal compliance, cost reduction, M&A, capital raising, culture and value creation. He previously served as Managing Director of Whittens & McKeough prior to the acquisition by Automic Group, where he was Head of Professional Services. Prior to joining Recce's Board of Directors, he served as the Company Secretary and primary legal advisor. He will also assume the role of Chair of the Company's Audit & Risk Management Committee. Mr. McKeough is currently the Chair of the Waratah Education Foundation. Ms. Niewidok is an experienced company secretary, having worked across a broad industry base of public companies. As Company Secretary, she will be responsible for communications between the Company and ASX.